Objectives. To find out whether patients with psoriatic arthritis (PsoA) have an increased prevalence of antibodies to gliadin (AGA) and of coeliac disease.
In a previous screening study of 302 patients with psoriasis vulgaris (PsoV), 16% were found to have immunoglobulin A (IgA) antibodies to gliadin (AGA) w1x. The majority of AGA-positive patients had no serum antibodies to endomysium. Endomysium antibodies are markers of coeliac disease, but the absence of these antibodies does not preclude the presence of gluten sensitivity. Although the increase in intraepithelial lymphocytes in the duodenal mucosa was mild in 40% and seemingly absent in 60% of IgA AGApositive PsoV patients w2x, a controlled study of the effects of a gluten-free diet showed that there was a significant improvement of the psoriasis w3x. The mechanisms of the improvement are not yet known.
In a study of palmoplantar pustulosis (PPP), which is considered to be a localized form of pustular psoriasis and, like psoriasis, is associated with arthropathy and spondylarthropathy, it was found that 8% of the patients had coeliac disease and 24% had IgA antibodies to gliadin w4x. Recently, we reported that PPP may be an autoimmune disease in which the autoantigen(s) are localized to the dermal papillary endothelium and which is associated with both nicotinic acetylcholine receptor antibodies and antibodies to gliadin and thyroglobulin w5x.
Recently, a greatly increased prevalence of coeliac disease has also been reported in Sjö gren's syndrome w6x. Interestingly, there is an increased prevalence of antibodies to muscarinic acetylcholine receptors in Sjö gren's syndrome w7x.
An association between rheumatoid arthritis and coeliac disease has also been discussed, and there are a number of case reports of clearance of the arthritis after coeliac disease had been diagnosed. There is one report of increased prevalence of IgA AGA, but the results were considered to be non-specific as there were no reticulinuendomysium antibodies w8x.
Arthritis is a complication of various types of enteropathy w9x as well as of coeliac disease w10x. Twenty-five per cent of patients with coeliac disease were reported to have concomitant arthritis, which was peripheral, axial or both w11x. Bourne et al. w12x reported that six patients with seronegative arthritis improved with a gluten-free diet after diagnosis of coeliac disease.
An increased prevalence of psoriasis has been found both in patients with Crohn's disease w13x and in those with ulcerative colitis w14x, whereas it is not known if there is an association between psoriatic arthritis (PsoA) and coeliac disease. We therefore undertook a screening study of patients with PsoA in order to find out whether this group has an increased prevalence of coeliac disease anduor increased levels of AGA and antibodies to endomysium, and if so, to relate the results to the patterns of serum IgA, IgG and IgM concentrations and to anamnestic and clinical data associated with the subgroups of psoriatic arthritis as defined by Moll and Wright w15x.
Patients and methods

Patients
This cross-sectional study included 114 consecutive patients with PsoA, as defined by Moll and Wright w15x, who were attending the psoriatic arthritis unit of our department of rheumatology between April 1997 and January 1999. Six of the patients were positive for rheumatoid factor. They were not excluded as they had spondylarthropathy and did not fulfil the criteria for rheumatoid arthritis. There were 57 women and 57 men, with a mean age of 50 " 14 yr (range 18-77 yr). The average age at onset of psoriasis was 31 " 16 yr and of PsoA 40 " 15 yr. The mean duration of the skin disease was 20 " 13 yr and of arthritis 11 " 10 yr. Seven per cent had a history of guttate psoriasis. The skin disease preceded the arthritis in 88% of the patients.
A structured interview with questions concerning psoriasis and arthritis and also autoimmune diseases, Crohn's disease, ulcerative colitis, coeliac disease, atopic disease, food intolerance, smoking habits and alcohol consumption was conducted with each patient by one of the investigators (UL). Anamnestic data were verified in the patient's previous medical records. The patient's history of inflammatory bowel disease and coeliac disease was accepted if the diagnosis had been verified by biopsy and of lactose intolerance if a lactose tolerance test had been performed. The patients were examined by both a rheumatologist (UL) and a dermatologist (Å B). The skin lesions were evaluated by the use of the psoriasis area severity index (PASI) score, including the degrees of erythema, infiltration and scaling, and estimation of the percentage of skin area involved w16x. The numbers of tender (68 joints) and swollen (66 sites) joints were recorded. Patients with inflammatory back pain w17x were evaluated by radiological examination of the sacroiliac joints and symptomatic parts of the spine. Axial enthesitis, including sacroiliitis grade 2, was recorded. Symptomatic peripheral joints were examined radiologically if this examination had not been performed previously.
Disease activity was evaluated with an overall clinical global assessment (five-step categorical rating scale from inactive to very severe disease).
The project was approved by the research ethics committee of Uppsala University and all patients gave their informed consent.
Antigliadin antibodies
IgA and IgG AGA were measured with an enzymelinked immunosorbent assay (ELISA) w18x with minor modifications as detailed previously w1x. Patients with values above the 90th percentile value of the reference group (IgA AGA 050 Uuml anduor IgG AGA 012 Uuml) were regarded as having an elevated AGA concentration (IgA AGA-or IgG AGA-positive). Reference sera were obtained from 129 blood donors (65 females and 64 males, age range 18-64 yr). The patients' sera were kept frozen (2708C) until analysed.
Antiendomysium antibodies
Serum IgA antibodies to endomysium (EmA) were assayed with a standard immunofluorescence method using cryostat sections of monkey oesophagus, as described previously w1x.
Immunoglobulins in serum
The concentrations of IgA, IgG and IgM were measured with a Beckman nephelometer (Array Protein System). Blood donors (age range 18-64 yr) served as a reference group.
Other analyses
In all patients, ESR (reference range: females 2-15 mmuh, males 2-10 mmuh), CRP (upper reference level 10 mgul) and serum alanine aminotransferase (ALAT) (upper reference level 0.8 mkatul) were measured by routine methods.
Statistical analysis
For analyses with the unpaired t-test and simple regression, Statview 4.5 (Abacus Concepts, Berkeley, CA, USA) was used.
Results
Medical history
Data on the occurrence of psoriasis, joint affection, inflammatory bowel disease and coeliac disease (based on answers to the questionnaire) among first-degree (parents, children, siblings) and second-degree relatives (grandparents, grandchildren, aunts and uncles, nieces and nephews) of the patients are shown in Table 1 . Of the seven patients having a family member with coeliac disease, one had six first-degree relatives and one second-degree relative with the disease, whereas the other six patients had one or two affected relatives.
As seen in Table 1 , five of the PsoA patients had biopsy-verified coeliac disease with villous atrophy. Lactose intolerance was present in four patients (one of whom had coeliac disease) and atrophic gastritis in one. In all the patients with coeliac disease, the joint symptoms were present before the coeliac disease was diagnosed. Seventeen per cent of all patients had concomitant autoimmune disease. Among the female patients, 19% had a history of thyroid disease (Grave's disease in two, unspecified hypothyroidism in five, unspecified thyroiditis in one, de Quervain's thyroiditis in two and toxic adenoma in one).
The most common aggravating factors for the psoriasis were stressudepression (45%), infections (16%) and alcohol intake (14%). Alcohol intake once or several times a week was reported by 18% of the male and 13% of the female patients. Sixteen per cent were smokers.
Clinical examination
Eighty-eight per cent of the patients had psoriasis vulgaris and 4.3% palmoplantar pustulosis. In 70% of the patients less than 5% of the skin surface was involved. More than 50% of patients were receiving systemic treatment (see below), whereas 15% had more widespread skin lesions. The nails were involved in 54%.
Sixty-three per cent of the patients had polyarthritis, 17% axial involvement, 14% oligoarthritis and 5% distal joint disease. One patient had arthritis mutilans. The mean number of swollen joints was 3.4 " 4.4 and of tender joints 6.6 " 8.1. Sixty-five per cent of the patients had a pathological radiology examination; 17% of all patients had sacroiliitis or spondyloarthritis.
Twenty-four per cent of the patients were taking oral methotrexate (dose range 7.5-15 mg once weekly), 8% sulphasalazine, 7% cyclosporin, 13% systemic corticosteroids and 51% non-steroidal anti-inflammatory drugs (NSAIDs).
IgA AGA As seen in Table 2 , the group of patients had a significantly higher mean value of IgA AGA than the reference group. In the patient group, 17.4% (11 men and eight women) had IgA AGA concentrations >50 Uul. The corresponding figure for the blood donors was 9.3% (six men and six women). The female patients had a lower mean IgA AGA concentration than the male patients, but the difference was not statistically significant (P = 0.0681). A raised IgA AGA concentration was not observed in any patient with serum IgA <1.5 gul (see below under Immunoglobulins in serum).
Only one of the 19 patients with raised IgA AGA had a history of atopy (cat, horse and birch pollen allergy).
IgG AGA There was no difference in the mean concentration of the 109 patients (4.9 " 3.2 Uul) and that of the 129 blood donors (5.1 " 7.4 Uul). Only three patients had an IgG AGA concentration >12 Uul. Two of them also had high concentrations of IgA AGA and one had a high concentration of IgG AGA but normal IgA AGA. There were no differences between the mean values for male and female patients.
IgA antibodies to endomysium
None of the sera were positive for IgA EmA. The two patients with the most recently diagnosed coeliac disease, who had partial villous atrophy, were also IgA EmA-negative before the start of their gluten-free diet.
Immunoglobulins in serum
The concentrations of IgA and IgM are shown in Table 3 and refer to analyses of 107 patient sera (patients with coeliac disease were excluded and values are missing for two patients). Figure 1 shows the percentile distributions of IgA concentration and Fig. 2 the percentile distributions of IgM concentration in the AGA-positive and AGA-negative male and female patients and in the reference group. These results show somewhat different patterns in men and women.
There was a highly significant increase in IgA in both male and female patients in comparison with the values in blood donors (Table 3 ). The increase was most pronounced in IgA AGA-positive patients; in IgA AGA-negative women the increase was small (P = 0.0613).
In male patients with a low alcohol intake (2-3 times a month or less, n = 36) the mean IgA concentration was 2.9 " 1.7 gul, and in males with a higher intake (once or several times a week, n = 12) it was 3.2 " 1.4 gul (not significant).
Seventeen per cent of the patients had a mild increase in ALAT values (>0.8 mkatul), but raised values were more common in patients with low alcohol intake than in those with a high intake.
As shown in Table 3 , both male and female patients showed a highly significant decrease in mean IgM concentration compared with the reference group. There was a significant inverse correlation between the IgA and IgM concentrations (r = 0.262, P = 0.0065).
In contrast to the low IgM concentration in the male IgA AGA-positive patients, the mean IgM concentration in the eight IgA AGA-positive women was not decreased. On the other hand, IgA AGA-negative 
All patients with thyroid disease were women.
female patients had a highly significantly decreased mean IgM concentration. The mean IgG concentration in the patient group (11.0 " 2.9 gul) was significantly higher than in the reference group (10.4 " 2.3 gul, P = 0.0295). The male patients without an increase in IgA AGA also showed a significant increase in their mean IgG concentration (11.2 " 2.6 gul, P = 0.0247 vs male blood donors), whereas the corresponding value for female patients did not differ from that of the female reference group.
Anamnestic and clinical data in IgA AGA-positive and -negative patients Three of the five patients with coeliac disease had firstdegree relatives with coeliac disease but none had a first-degree relative with inflammatory bowel disease. Among the IgA AGA-positive patients 5.2% had firstdegree relatives with Crohn's disease and 5.5% with ulcerative colitis. Among the IgA AGA-negative patients, 2.2% had a first-degree relative with Crohn's disease and 5.5% with ulcerative colitis. Two per cent of the IgA AGA-negative patients had a first-degree relative with gluten intolerance. When patients with coeliac disease were excluded, 41% of the patients had various gastrointestinal symptoms (nausea, abdominal distension, pain, flatulence, loose stools, constipation), which were equally common in AGA-positive and -negative patients. The symptoms were not related to the medication, as they were equally common in those who did and did not use NSAIDs anduor methotrexate. Sixteen per cent of the AGA-positive and 11% of the AGA-negative patients said that they were intolerant of gluten anduor milk, with gastrointestinal symptoms after intake of these items. Four of the patients with milk intolerance had an abnormal lactose tolerance test; in the other patients no attempts to verify food intolerance had been performed.
The proportion of patients with thyroid disease was similar in those with and without a raised IgA AGA concentration, but two of four women with coeliac disease had hypothyroidism. Table 4 shows the type of arthritis in coeliac disease patients and in those with and without IgA AGA. None of the patients in the subgroup with distal joint involvement had a raised IgA AGA concentration (n = 6, mean IgA AGA 16.0 " 7.3 Uul), whereas in the other subgroups of arthritis 6-20% of patients had a raised IgA AGA concentration.
Forty per cent of the patients with coeliac disease, 39% of the AGA-positive patients and 32% of the AGA-negative patients had more than five erosions.
Compared with patients with a low IgA AGA concentration, patients with a raised IgA AGA concentration had a significantly higher ESR (29 vs 18 mmuh, P = 0.037) and CRP concentration (26 vs 16mgul, P = 0.049) and they also reported a longer duration of morning stiffness (1.79 vs 1.09 h, P = 0.0102).
All five of the patients with coeliac disease had received treatment with methotrexate, compared with about 25% of both IgA AGA-positive and -negative patients.
Discussion
The results show that there is an increased prevalence of raised IgA AGA and of coeliac disease in patients with PsoA. There are also significant changes in serum immunoglobulins, with increased IgA and decreased IgM.
An increased prevalence of coeliac disease in patients with PsoA has not been reported previously. Among our patients, 4.4% had coeliac disease (ascertained by the presence of villous atrophy) compared with 0.4% in a large Swedish adult population of blood donors w19x. The figure for coeliac disease in the PsoA patients may   FIG. 2. Box plots demonstrating the 10th, 25th , 50th, 75th and 90th percentiles for serum IgM concentration in men and women with IgA AGA (050 Uul, IgA AGA + ) and without IgA AGA ((50 Uul, IgA AGA 2 ) and in the reference group. P values are given in Table 3 . Whether the same good results as in AGA-positive PsoV patients can be obtained in PsoA if a gluten-free diet is started early in the course of arthritis is not known, but there is at least one case report of the clearance of PsoA after diagnosis of coeliac disease w20x. That gluten sensitivity can be of importance in PsoA is also illustrated by the observation of a severe exacerbation of arthritis and skin lesions after gluten challenge in two of our PsoA patients with coeliac disease w3x. Furthermore, the patients in this study who had PsoA and coeliac disease or IgA AGA had more pronounced systemic disease activity, with higher ESR and CRP and longer morning stiffness, and also a tendency to more erosions, than the IgA AGA-negative patients.
The relationship between Crohn's disease, ulcerative colitis and coeliac disease has been debated. Elevated levels of IgA AGA have been reported both in Crohn's disease w21x and in ulcerative colitis w22x but have been considered non-specific, as IgA antibodies to endomysium and to reticulin were negative. However, none of our patients with a raised IgA AGA concentration had a history of Crohn's disease or ulcerative colitis, but both AGA-positive and -negative patients had a high percentage of relatives with these diseases.
None of the PsoA patients had a raised IgA EmA concentration. This observation is similar to the findings in the patients with PsoV; in this group only one out of 33 of those who were AGA-positive was positive for IgA EmA and one was on the borderline w3x. Whether the negativity for EmA in PsoA reflects less pronounced mucosal lesions or a different type of reactivity to gluten compared with those who are positive for EmA is not known. It is established, however, that not all patients with gluten sensitivity are EmA-positive w23x. Thus, in a recent study only one in six patients with partial atrophy had a raised EmA concentration, and patients with increased lymphocyte infiltration in the duodenal epithelium but without villous atrophy are usually EmA-negative w24x.
The serum IgA concentration was increased and the IgM concentration was decreased in both AGA-positive and AGA-negative PsoA patients. A similar pattern is present in patients with coeliac disease and dermatitis herpetiformis. The increase in serum IgA is more pronounced in PsoA than in PsoV; the serum IgA concentration was raised in male patients, whereas in female patients the serum IgA concentration was significantly increased only in those with a raised serum IgA AGA concentration w1x. The mean serum IgM concentration was not decreased in PsoV. On the other hand, in PPP the mean serum IgA concentration was elevated and the IgM concentration decreased, with mean concentrations similar to those in PsoA w4x. In PPP, inflammation in the skin is very intense and PPP is also the variant of psoriasis with the highest prevalence of coeliac disease and of IgA AGA.
In PsoA as well as in PsoV w1x and in PPP w4x, patients with a raised serum IgA AGA concentration had the highest serum IgA concentration, and therefore it seems likely that reactivity to gliadin stimulates IgA production.
Whether the increase in IgA concentration in the AGA-negative patients can be linked to other processes in the gut is not known. For instance, increased levels of IgA anti-bodies to cytokeratin 18 and epidermal keratins have been reported in both PsoA and rheumatoid arthritis and might contribute to the raised serum level of IgA w25x. It has also been speculated that bacterial infections in the mucosal system might be responsible for an increase in the serum IgA concentration w26x. Schatteman et al. w27x performed ileocolonoscopy and found inflammatory lesions in 20% of the patients with psoriatic oligoarthritis and in 30% of those with axial involvement, indicating that the gut may play a role in the inflammation. However, there was no information about AGA or serum IgA and IgM in their report. Some types of PsoA might be more common than others in AGA-positive patients. Thus, none of our patients with distal joint arthritis were AGApositive, whereas in the other subgroups 6-20% were AGA-positive.
A high alcohol intake may contribute to raised serum IgA concentration. There was a tendency to higher serum IgA concentrations in male patients consuming alcohol once or several times weekly than in those who consumed less alcohol. On the other hand, raised ALAT values were more common in those with low alcohol intake. Therefore, it seems less likely that the high serum IgA concentration can be linked to alcohol consumption. Another possibility is that disturbed liver function in PsoA leads to less effective elimination of IgA. In this context, it is of interest that associations of both psoriasis w28x and coeliac disease w29x with biliary cirrhosis have been reported. Some of the anamnestic and clinical data deserve comment. Gastrointestinal symptoms and a history of intolerance to various food items were equally common in AGA-positive and -negative patients and could not be linked to the use of NSAIDs or methotrexate.
The food items thought not to be tolerated were predominantly gluten and milk. This assumption needs confirmation by objective methods, as in many cases subjective food intolerance cannot be proved in provocations. The question of whether the symptoms might be associated with abnormalities in the intestinal mucosa needs to be addressed in further studies.
Autoimmune thyroid disease was more common among the female PsoA patients than in the population at large. The prevalence of vitiligo was also increased. In north-west Europe, the prevalences of these disorders are 2.7% w30x and 0.38% w31x respectively. This indicates that there may be a link to autoimmune disorders in PsoA, as has also been reported recently in PPP w4x. It is not yet known if PsoA as well as PsoV and PPP patients with AGA carry the same genes, i.e. DQ A1*0501uDQ B1*0102 and DQ A 1*0301uDQ B1*0302, which predominate in patients with coeliac disease w32x.
In this study of patients with PsoA, we found an increased prevalence of coeliac disease and of raised IgA AGA as well as an increased serum IgA concentration and a decreased IgM concentration. Studies of the gastrointestinal mucosa in PsoA patients are therefore needed. Controlled studies of the effects of a gluten-free diet on the severity of PsoA are also required.
